Blockchain-based technologies to facilitate traceability of products through their lifecycle, including design, development, manufacturing, supply chain, and use. The system provides transparent, secure traceability through product lifecycle, drawing insights from collected data and post-market activities. For example, the system could receive tracking data from a plurality of tracking sources along a product's lifecycle and generate one or more blocks in a blockchain to capture the tracking data from the plurality of tracking sources along the product's lifecycle in one or more distributed ledgers.
Legal claims defining the scope of protection. Each claim is shown in both the original legal language and a plain English translation.
2. The computing system of claim 1, further comprising one or more instructions to generate one or more blocks in the blockchain responsive to receiving tracking data from one or more of the plurality of tracking sources along the medical device lifecycle.
This invention relates to a computing system for tracking medical devices throughout their lifecycle using blockchain technology. The system addresses the challenge of ensuring secure, tamper-proof documentation of medical device data across multiple stages, including manufacturing, distribution, usage, and maintenance. The system collects tracking data from various sources such as manufacturers, distributors, healthcare providers, and maintenance personnel. This data includes information about device specifications, usage history, maintenance records, and any reported issues. The system processes this data to generate blocks in a blockchain, ensuring that all tracking information is cryptographically secured and immutable. Each block contains timestamped records of device activities, forming a verifiable audit trail. The blockchain structure prevents unauthorized modifications, enhancing data integrity and trust among stakeholders. The system also allows authorized users to query the blockchain for device-specific information, enabling real-time verification of device status and history. This approach improves regulatory compliance, supply chain transparency, and patient safety by providing a reliable record of a medical device's entire lifecycle.
3. The computing system of claim 2, wherein to generate one or more blocks in the blockchain comprises triggering generating the one or more blocks responsive to receiving tracking data from one or more of the plurality of tracking sources along the medical device lifecycle.
This invention relates to a computing system for managing blockchain-based tracking of medical devices throughout their lifecycle. The system addresses the challenge of ensuring secure, tamper-proof documentation of medical device data across multiple stages, including manufacturing, distribution, usage, and maintenance. The system collects tracking data from various sources along the medical device lifecycle, such as sensors, databases, or user inputs, and uses this data to generate blocks in a blockchain. Each block contains timestamped records of device status, location, or other relevant information, ensuring an immutable audit trail. The blockchain structure prevents unauthorized modifications, enhancing data integrity and regulatory compliance. The system may also validate the tracking data before incorporating it into the blockchain, ensuring accuracy and reliability. This approach improves traceability, reduces counterfeit risks, and supports compliance with healthcare regulations. The invention is particularly useful in environments where medical device integrity and provenance are critical, such as hospitals, pharmaceutical supply chains, or medical device manufacturers.
4. The computing system of claim 1, wherein the plurality of tracking sources comprises tracking data representing one or more of design, manufacturing, or supply chain events regarding an individual medical device.
This invention relates to a computing system for tracking medical devices throughout their lifecycle, addressing challenges in monitoring design, manufacturing, and supply chain events for individual devices. The system collects and processes tracking data from multiple sources, including sensors, databases, and manual inputs, to create a comprehensive record of each device's history. This data encompasses design specifications, manufacturing processes, and supply chain movements, enabling traceability and quality control. The system analyzes the tracking data to detect anomalies, predict failures, or verify compliance with regulatory standards. By integrating diverse tracking sources, the system ensures real-time visibility into the lifecycle of each medical device, improving safety, efficiency, and accountability in healthcare supply chains. The invention supports automated alerts, reporting, and decision-making based on the aggregated tracking data, enhancing operational transparency and reducing risks associated with device performance and regulatory adherence.
5. The computing system of claim 4, wherein the individual medical device comprises one or more of an embedded medical device or a pharmaceutical product.
This invention relates to computing systems for managing and monitoring medical devices and pharmaceutical products. The system addresses the challenge of securely and efficiently tracking the status, usage, and performance of medical devices and pharmaceuticals in healthcare environments. The system includes a computing device with a processor and memory storing instructions for monitoring the medical devices and pharmaceutical products. The system is configured to receive data from the medical devices and pharmaceutical products, process this data to determine their operational status, and generate alerts or notifications based on predefined criteria. The system can also transmit control signals to the medical devices to adjust their operation or settings. The medical devices and pharmaceutical products may include embedded sensors or tracking mechanisms to provide real-time data to the computing system. The system ensures compliance with regulatory requirements, enhances patient safety, and improves the efficiency of healthcare operations by providing centralized monitoring and control capabilities. The invention aims to integrate various medical devices and pharmaceutical products into a unified system, enabling seamless data exchange and coordination between different healthcare components.
6. The computing system of claim 4, further comprising one or more instructions to enroll the individual medical device in a clinical study, wherein to generate comprises generating one or more blocks in the blockchain that link tracking data representing one or more of reprocessing or sterility cycle information regarding the individual medical device with the unique identifier for the clinical study.
This invention relates to a computing system for managing medical device tracking and clinical study enrollment using blockchain technology. The system addresses challenges in securely and transparently tracking medical devices, particularly their reprocessing and sterility cycles, while ensuring data integrity and traceability for clinical studies. The computing system includes instructions to generate a blockchain that links tracking data for an individual medical device with a unique identifier for a clinical study. The tracking data includes reprocessing and sterility cycle information, ensuring that each device's history is recorded immutably. The system also enrolls the medical device in a clinical study, with the blockchain generating one or more blocks that associate the device's tracking data with the study's unique identifier. This ensures that the device's usage and reprocessing history are verifiable and tamper-proof, supporting regulatory compliance and study integrity. The blockchain structure provides a decentralized and transparent ledger, allowing authorized parties to audit the device's lifecycle while preventing unauthorized modifications. This approach enhances trust in clinical study data by ensuring that device tracking information remains accurate and traceable throughout the study. The system improves efficiency in clinical trials by automating data linkage and reducing manual record-keeping errors.
7. The computing system of claim 4, wherein to generate comprises generating one or more blocks in the blockchain that link adverse event data representing one or more of a recall or a field action event regarding the individual medical device with the unique identifier for the individual medical device.
This invention relates to a computing system for tracking and managing adverse events related to medical devices using blockchain technology. The system addresses the challenge of securely and transparently recording and linking adverse event data, such as recalls or field action events, to specific medical devices identified by unique identifiers. The system generates one or more blocks in a blockchain that contain adverse event data and establish a link between this data and the unique identifier of the affected medical device. This ensures an immutable and auditable record of adverse events, enhancing traceability and accountability in medical device safety monitoring. The blockchain structure provides a decentralized and tamper-resistant ledger, improving trust and reliability in the reporting and tracking of device-related incidents. The system may also include additional features such as generating alerts, notifying stakeholders, and facilitating regulatory compliance by maintaining a verifiable history of adverse events associated with individual medical devices. This approach helps manufacturers, regulators, and healthcare providers quickly identify and address safety issues, reducing risks to patient health.
8. The computing system of claim 7, further comprising one or more instructions to generate an alert responsive to one or more blocks in the blockchain including adverse event data.
A computing system monitors a blockchain network to detect adverse events recorded in the blockchain. The system includes a processor and memory storing instructions that, when executed, cause the system to analyze blocks in the blockchain for adverse event data. Adverse events may include security breaches, fraudulent transactions, or other anomalies that deviate from expected blockchain operations. The system processes the blockchain data to identify these events, which may be defined by predefined criteria or machine learning models trained to recognize patterns indicative of adverse conditions. Upon detecting such events, the system generates an alert to notify administrators or other stakeholders. The alert may include details about the event, such as the block identifier, timestamp, and nature of the adverse event. The system may also log the event for further investigation or integrate with other security or monitoring tools to trigger automated responses. This approach enhances blockchain transparency and security by proactively identifying and reporting potential issues.
9. The computing system of claim 4, further comprising selectively providing access to one or more users to the one or more blocks in the blockchain with an interface that presents one or more blocks in the blockchain as a function of the unique identifier for the individual medical device.
This invention relates to a computing system for managing blockchain-based data access for medical devices. The system addresses the challenge of securely and selectively sharing medical device data stored in a blockchain, ensuring that only authorized users can access relevant information while maintaining data integrity and traceability. The computing system includes a blockchain storing data in blocks, where each block is associated with a unique identifier for an individual medical device. The system further includes an interface that selectively provides access to one or more users based on their authorization. The interface presents blocks in the blockchain as a function of the unique identifier, allowing users to retrieve data specific to a particular medical device. This ensures that users can only access data linked to devices they are authorized to view, enhancing security and privacy. The system may also include a processor that executes instructions to perform operations such as generating, storing, and retrieving blockchain data, as well as managing user access permissions. The blockchain may be configured to store device-specific data, such as usage logs, maintenance records, or diagnostic information, in a tamper-proof manner. The interface may further include features like search functionality, filtering options, or visualization tools to improve usability. By linking blockchain data to unique medical device identifiers, the system enables efficient and secure data management, reducing the risk of unauthorized access while ensuring data accuracy and traceability. This approach is particularly useful in healthcare environments where regulatory compliance and data security are critical.
11. The non-transitory computer-readable medium of claim 10, further comprising one or more automated routines to automate generation of one or more blocks in the blockchain responsive to receiving tracking data from one or more of the plurality of tracking sources along the medical device lifecycle.
This invention relates to blockchain-based systems for tracking medical devices throughout their lifecycle, addressing challenges in ensuring data integrity, traceability, and compliance in medical device supply chains. The system automates the generation of blockchain blocks in response to tracking data received from multiple sources, such as manufacturers, distributors, healthcare providers, and regulatory bodies. The blockchain records critical events, including device manufacturing, distribution, usage, maintenance, and disposal, creating an immutable audit trail. Automated routines process incoming tracking data, validate its authenticity, and generate corresponding blockchain entries, ensuring real-time updates and reducing manual errors. The system enhances transparency, simplifies regulatory compliance, and improves recall management by providing a tamper-proof record of a device's entire lifecycle. The blockchain structure ensures data integrity, while automated routines streamline the recording process, making it scalable for large-scale medical device tracking. This approach mitigates risks associated with counterfeit devices, improves patient safety, and supports efficient supply chain management. The invention is particularly useful in healthcare environments where accurate tracking and traceability are critical for regulatory adherence and operational efficiency.
12. The non-transitory computer-readable medium of claim 11, wherein the one or more automated routines are to generate one or more blocks in the blockchain as a function of a respective tracking source of the plurality of tracking sources in response to receiving tracking data from one or more of the plurality of tracking sources along the medical device lifecycle.
This invention relates to a system for tracking medical devices throughout their lifecycle using blockchain technology. The problem addressed is the lack of a secure, tamper-proof method for recording and verifying the provenance, usage, and maintenance history of medical devices, which is critical for patient safety, regulatory compliance, and supply chain management. The system involves a non-transitory computer-readable medium storing instructions that, when executed, perform automated routines to generate blocks in a blockchain. These blocks are created based on tracking data received from multiple tracking sources along the medical device lifecycle. The tracking sources may include manufacturing records, distribution logs, usage data from healthcare facilities, maintenance records, and disposal documentation. Each block in the blockchain is generated as a function of the respective tracking source, ensuring that the data is cryptographically secured and immutable. The blockchain structure provides a decentralized ledger that can be audited by authorized parties, such as regulators, manufacturers, and healthcare providers, to verify the authenticity and integrity of the medical device's history. This approach enhances traceability, reduces the risk of counterfeit devices, and ensures compliance with regulatory requirements. The system may also include mechanisms for validating the tracking data before it is recorded in the blockchain, ensuring accuracy and reliability.
13. The non-transitory computer-readable medium of claim 10, wherein to generate comprises generating the one or more blocks in the blockchain that uniquely identify an individual medical device.
This invention relates to blockchain technology applied to medical device identification and tracking. The problem addressed is the need for secure, tamper-proof methods to uniquely identify and authenticate medical devices throughout their lifecycle, ensuring traceability and preventing counterfeit devices from entering the supply chain. The invention involves a computer-readable medium storing instructions for generating one or more blocks in a blockchain that uniquely identify an individual medical device. Each block in the blockchain contains data that links to the specific device, ensuring that the identification is immutable and verifiable. The blockchain structure provides a decentralized ledger where each entry is cryptographically secured, making it resistant to alteration or fraud. This system allows for real-time tracking of medical devices from manufacturing to deployment, ensuring compliance with regulatory standards and enhancing patient safety. The blockchain-based approach enables multiple stakeholders, including manufacturers, distributors, and healthcare providers, to access and verify the authenticity and history of a medical device. By storing device-specific data in the blockchain, the system ensures that any attempt to tamper with the identification is detectable, thereby maintaining the integrity of the medical device supply chain. This method improves transparency, reduces the risk of counterfeit devices, and supports regulatory requirements for device tracking and recall management.
14. The non-transitory computer-readable medium of claim 13, wherein the plurality of tracking sources comprises tracking data representing one or more of design, manufacturing, and supply chain events regarding the individual medical device.
This invention relates to a system for tracking medical devices using a non-transitory computer-readable medium that stores tracking data from multiple sources. The system addresses the challenge of maintaining accurate and comprehensive records of medical devices throughout their lifecycle, including design, manufacturing, and supply chain stages. The tracking data includes information about events such as design modifications, production processes, and logistics movements, ensuring traceability and regulatory compliance. The system aggregates and organizes this data to provide a unified view of a medical device's history, enabling better quality control, recall management, and compliance with industry regulations. By integrating data from diverse sources, the system enhances transparency and reduces errors in tracking medical devices from development to deployment. The invention improves efficiency in supply chain management and ensures that all relevant events are documented for auditing and safety purposes. This approach supports real-time monitoring and historical analysis, helping manufacturers and regulators maintain high standards of safety and accountability.
15. The non-transitory computer-readable medium of claim 10, further comprising one or more instructions to enroll the individual medical device in a clinical study, wherein to generate comprises generating one or more blocks in the blockchain that link tracking data representing one or more of reprocessing or sterility cycle information regarding the individual medical device with the unique identifier for the clinical study.
This invention relates to a system for tracking and managing medical devices, particularly in the context of clinical studies. The system addresses the challenge of securely and transparently recording device reprocessing and sterility cycle data to ensure compliance with regulatory requirements and study protocols. The invention involves a blockchain-based approach to store and link tracking data associated with individual medical devices to unique identifiers for clinical studies. The blockchain structure ensures data integrity, immutability, and traceability, allowing stakeholders to verify the history of each device's reprocessing and sterility cycles. The system includes instructions to enroll medical devices in clinical studies, where the enrollment process involves generating blockchain blocks that associate the device's tracking data—such as reprocessing details and sterility cycle information—with the study's unique identifier. This linkage ensures that all relevant data is securely recorded and accessible, facilitating audits and regulatory compliance. The blockchain's decentralized nature prevents unauthorized modifications, enhancing trust in the data's accuracy. The invention improves clinical study management by providing a tamper-proof record of device usage, reducing risks of contamination or non-compliance, and streamlining verification processes.
16. The non-transitory computer-readable medium of claim 15, wherein to generate comprises generating one or more blocks in the blockchain that link adverse event data representing one or more of a recall or a field action event regarding the individual medical device with the unique identifier for the individual medical device.
This invention relates to blockchain-based systems for tracking adverse events in medical devices. The problem addressed is the lack of a secure, tamper-proof method for recording and linking adverse events, such as recalls or field actions, to specific medical devices. The solution involves a blockchain system that generates blocks containing adverse event data, which are then linked to the unique identifiers of the affected medical devices. This ensures traceability and integrity of the data, allowing for accurate tracking of device performance and safety issues. The system may also include generating a blockchain that records device usage data, such as patient interactions, to further enhance monitoring. By storing this information in an immutable blockchain, the system provides a reliable audit trail for regulatory compliance and post-market surveillance. The invention improves transparency and accountability in medical device safety management.
17. The non-transitory computer-readable medium of claim 16, further comprising one or more instructions to generate an alert responsive to one or more blocks in the blockchain that includes adverse event data.
A system monitors blockchain data to detect adverse events and generate alerts. The system processes blockchain transactions to identify blocks containing adverse event data, such as security breaches, fraud, or other irregularities. When such data is detected, the system triggers an alert to notify relevant parties, such as administrators or security teams. The alert may include details about the adverse event, including the block's timestamp, transaction hash, and other relevant metadata. The system may also analyze the blockchain for patterns or anomalies that indicate potential threats, enhancing the detection process. By continuously monitoring the blockchain, the system ensures timely identification and response to adverse events, improving security and operational efficiency in blockchain-based applications. The alert mechanism may be integrated with existing security protocols or notification systems to streamline incident response. This approach helps organizations maintain trust and integrity in blockchain networks by proactively addressing potential risks.
18. The non-transitory computer-readable medium of claim 16, further comprising one or more instructions to selectively provide access to one or more users to the one or more blocks in the blockchain with an interface that presents one or more blocks in the blockchain as a function of the unique identifier for the individual medical device.
This invention relates to blockchain-based systems for managing medical device data. The problem addressed is the need for secure, traceable, and user-specific access to medical device records stored in a blockchain. The system uses a blockchain to store data blocks associated with medical devices, where each block is linked to a unique identifier for an individual medical device. The invention enhances this by providing a user interface that selectively grants access to one or more blocks in the blockchain based on the unique identifier. This allows different users to view only the relevant blocks associated with specific medical devices, ensuring data privacy and security. The interface dynamically presents blocks as a function of the device identifier, enabling tailored access control. The system may also include additional features such as generating and storing blockchain blocks containing device data, validating blocks, and managing access permissions. The overall solution improves medical device data management by ensuring that only authorized users can access relevant records, reducing the risk of unauthorized access while maintaining the integrity and traceability of the data.
Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.
April 27, 2021
April 30, 2024
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.